Exenatide Once Weekly for Alcohol Use Disorder Investigated in a Randomized, Placebo-Controlled Clinical Trial
35 A total of 56 patients was assessed using the ChildPugh criteria and grouped into either normal, mild, moderate, or severe hepatic impairment
Exendin-4 was eventually developed into exenatide, a treatment for diabetes and the first GLP-1 receptor agonist approved for medical use
Ms all de apoyar la prdida de grasa, tambin contribuye a mejorar los niveles de energa y el bienestar general , ayudando a las personas a avanzar hacia un estilo de vida ms saludable y sostenible
Since it is prescribed long-term for Type 2 Diabetes and chronic weight management, many people start looking for cheaper options
Other potential side effects include changes in appetite, headache, and fatigue